Harris Kaplan Reflects on Future of Obesity Market in “The Pink Sheet”Print this Page

Healogix CEO Harris Kaplan discusses the future of drug development for obesity in the June 1 issue of “The Pink Sheet.” If you would like to read the article please click on the link below. You will need to be a current subscriber of the “The Pink Sheet”.

http://www.thepinksheet.com/fdcreports/story/viewStory.do?targetAN=00710220009